SCHEMBL7065043

SCHEMBL7065043

O=C(O)COc1cc(Cl)ccc1C(=O)NCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 9/20 0.75
AKR1B10 O60218 1/20 0.66
APEX1 P27695 1/20 0.51
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 2/20 0.49
LMNA P02545 1/20 0.48
AKR1C3 P42330 1/20 0.48
TAOK1 Q7L7X3 1/20 0.47
TAOK3 Q9H2K8 1/20 0.47
MAPT P10636 1/20 0.47
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064934 0.90 AKR1B1 (0.86) AKR1B1AKR1B10TDP1TSHRAKR1C3
SCHEMBL5470955 0.86 AKR1B1 (0.80) AKR1B1AKR1B10TDP1LMNAAKR1C3
SCHEMBL7059964 0.86 AKR1B1 (1.00) AKR1B1AKR1B10TDP1TSHRAKR1C3
SCHEMBL7063273 0.85 AKR1B1 (0.77) AKR1B1AKR1B10LMNAAKR1C3MAPT
SCHEMBL14447219 0.83 AKR1B1 (0.71) AKR1B1AKR1B10TDP1TSHRLMNA
SCHEMBL7066939 0.83 AKR1B1 (0.71) AKR1B1AKR1B10APEX1LMNAAKR1C3
SCHEMBL5470902 0.82 AKR1B1 (0.67) AKR1B1AKR1B10TSHRLMNAMAPT
SCHEMBL7063237 0.82 AKR1B1 (0.72) AKR1B1AKR1B10AKR1C3ALDH1A1GAA
SCHEMBL7064945 0.81 AKR1B1 (0.69) AKR1B1AKR1B10TDP1TSHRLMNA
SCHEMBL4674096 0.81 CCR3 (0.57) AKR1B1AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US claimed
US-6420426-B1 USED TO TREAT COMPLICATIONS FROM DIABETES MELLITUS THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2002-07-16 US claimed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US disclosed
EP-1198451-A2 SUBSTITUTED PHENOXYACETIC ACIDS The Institutes for Pharmaceutical Discovery, LLC (US) 2002-04-24 EP disclosed
WO-2001000566-A2 SUBSTITUTED PHENOXYACETIC ACIDS THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161631-A1 Substituted Phenoxyacetic Acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885APEX1 4643/4885
US-20030036558-A1 Substituted phenoxyacetic acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885APEX1 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.